| P50 | author | Andrew J. Baillie | Q43057374 |
| | Kirsten Morley | Q57072925 |
| P2093 | author name string | S Leung | |
| | L Leggio | |
| | P S Haber | |
| | G Addolorato | |
| P2860 | cites work | CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials | Q24614759 |
| | GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence | Q27026530 |
| | Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics | Q29395989 |
| | The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 |
| | The role of the orbitofrontal cortex in anxiety disorders | Q31121810 |
| | Mixed effects logistic regression models for longitudinal binary response data with informative drop-out. | Q32067819 |
| | Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam | Q33993651 |
| | Drug harms in the UK: a multicriteria decision analysis | Q34024516 |
| | Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale | Q34043779 |
| | Baclofen administration for the treatment of affective disorders in alcoholic patients | Q34061029 |
| | Effectiveness and safety of baclofen in the treatment of alcohol dependent patients | Q34101993 |
| | Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial | Q34246904 |
| | Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). | Q34476552 |
| | Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study | Q34722965 |
| | A human laboratory pilot study with baclofen in alcoholic individuals | Q34871492 |
| | Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. | Q35766754 |
| | Acute interaction of baclofen in combination with alcohol in heavy social drinkers | Q37060525 |
| | Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection | Q37156172 |
| | Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study | Q37163680 |
| | Role of the GABA(B) receptor in alcohol-seeking and drinking behavior | Q37632745 |
| | Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues | Q37679328 |
| | Safety and efficacy of baclofen in the treatment of alcohol-dependent patients | Q37756203 |
| | Comorbid psychiatric disorders predict and influence treatment outcome in female alcoholics | Q40606993 |
| | Role of gamma-aminobutyric acid in antipanic drug efficacy | Q41268652 |
| | Baclofen for alcohol dependence: a preliminary open-label study | Q42642535 |
| | The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders | Q43617447 |
| | Changes in psychological symptoms during ambulant detoxification | Q43988675 |
| | Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study | Q44129398 |
| | Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. | Q44203742 |
| | Baclofen treatment for chronic posttraumatic stress disorder | Q44551415 |
| | Anxiety status affects nicotine- and baclofen-induced locomotor activity, anxiety, and single-trial conditioned place preference in male adolescent rats | Q47890802 |
| | Baclofen add-on to citalopram in treatment of posttraumatic stress disorder | Q48352115 |
| | The effect of depression on return to drinking: a prospective study. | Q50901534 |
| | Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. | Q51001303 |
| | Psychometric properties of the Penn Alcohol Craving Scale. | Q52277465 |
| | Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial | Q63464422 |
| | Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations | Q68447241 |
| | Alcohol dependence syndrome: measurement and validation | Q70404143 |
| | Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial | Q73665552 |
| P433 | issue | 6 | |
| P921 | main subject | alcohol dependence | Q4713263 |
| P304 | page(s) | 654-660 | |
| P577 | publication date | 2014-09-21 | |
| P1433 | published in | Alcohol and Alcoholism | Q15751935 |
| P1476 | title | Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety | |
| P478 | volume | 49 | |